$2970 | Single User
$5400 | Site License
$8500 | Enterprise License

Cholera Forecast for selected Asian Markets 2017-2027
[Lowest Price Guaranteed: $2,970]

Published by Black Swan Analysis: 01 Jan 2017 | 81392 | In Stock
Related Topics: Delivery

Introduction

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Cholera for Selected Asian Markets

Cholera is a bacterial disease caused by infection from Vibrio cholerae species (O1, O139), usually spread through contaminated water. Cholera causes severe diarrhoea and dehydration. Left untreated, cholera can be fatal in a matter of hours, even in previously healthy people.

This report provides the current incidence population for Cholera for Selected Asian Markets (Cambodia, Indonesia, Lao PDR, and Viet Nam) split by gender and 5-year age cohort. Along with the current incidence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms of Cholera have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Risk factors for contracting cholera relate mostly to contaminated water and sanitation. The disease shows marked seasonality in developing nations, and outbreaks can occur during natural disasters (tsunamis) and complex emergencies (generally affecting the water supply / sanitation infrastructure).

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

• Able to quantify patient populations in global Cholera market to target the development of future products, pricing strategies and launch plans.

• Gain further insight into the incidence of the subdivided types of Cholera and identify patient segments with high potential.

• Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.

• Identify sub-populations within Cholera which require treatment.

• Gain an understanding of the specific markets that have the largest number of Cholera patients.

Table of Contents
for Cholera Forecast for selected Asian Markets 2017-2027

  • Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Cholera for Selected Asian Markets

    Cholera is a bacterial disease caused by infection from Vibrio cholerae species (O1, O139), usually spread through contaminated water. Cholera causes severe diarrhoea and dehydration. Left untreated, cholera can be fatal in a matter of hours, even in previously healthy people.

    This report provides the current incidence population for Cholera for Selected Asian Markets (Cambodia, Indonesia, Lao PDR, and Viet Nam) split by gender and 5-year age cohort. Along with the current incidence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

    Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms of Cholera have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

    Risk factors for contracting cholera relate mostly to contaminated water and sanitation. The disease shows marked seasonality in developing nations, and outbreaks can occur during natural disasters (tsunamis) and complex emergencies (generally affecting the water supply / sanitation infrastructure).

    This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

    Reason to buy

    • Able to quantify patient populations in global Cholera market to target the development of future products, pricing strategies and launch plans.

    • Gain further insight into the incidence of the subdivided types of Cholera and identify patient segments with high potential.

    • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.

    • Identify sub-populations within Cholera which require treatment.

    • Gain an understanding of the specific markets that have the largest number of Cholera patients.

List Of Tables
in Cholera Forecast for selected Asian Markets 2017-2027

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Cholera for Selected Asian Markets

Cholera is a bacterial disease caused by infection from Vibrio cholerae species (O1, O139), usually spread through contaminated water. Cholera causes severe diarrhoea and dehydration. Left untreated, cholera can be fatal in a matter of hours, even in previously healthy people.

This report provides the current incidence population for Cholera for Selected Asian Markets (Cambodia, Indonesia, Lao PDR, and Viet Nam) split by gender and 5-year age cohort. Along with the current incidence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms of Cholera have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Risk factors for contracting cholera relate mostly to contaminated water and sanitation. The disease shows marked seasonality in developing nations, and outbreaks can occur during natural disasters (tsunamis) and complex emergencies (generally affecting the water supply / sanitation infrastructure).


This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

• Able to quantify patient populations in global Cholera market to target the development of future products, pricing strategies and launch plans.

• Gain further insight into the incidence of the subdivided types of Cholera and identify patient segments with high potential.

• Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.

• Identify sub-populations within Cholera which require treatment.

• Gain an understanding of the specific markets that have the largest number of Cholera patients.

List Of Figures, Charts and Diagrams
in Cholera Forecast for selected Asian Markets 2017-2027

See List of Tables for the Figures

Additional Details

Publisher

Black Swan Analysis

Publisher Information

Black Swan Analysis, founded in 2007, is a unique analysis practice that provides robust valuations and commercialisation plans to optimise products in the healthcare industry. We know what it takes to succeed in this industry -we’ve seen what works and what doesn’t and we are committed to bringing insight and high quality solutions to our clients. In doing so we help them meet the many challenges of today’s complex healthcare marketplace.



The Black Swan team has a unique skill set: the ability to develop dynamic market forecasts and interactive patient flow models using a wide range of data including complex pathological and epidemiological information. As pharmaceutical and healthcare companies are challenged to deliver more specific targets that align with unmet medical needs. These modelling approaches are more commercially focused to meet the requirements of a changing healthcare environment.



We have the capability to provide an immediate and ‘hands-on’ approach with every client and where the right internal expertise is leveraged we can help find your optimal solution. Using our bespoke methodologies and frameworks we seek to assess the most challenging valuations.



The valuation outputs we generate can be easily integrated with any in-house existing financial systems, presentation styles or platforms that may be currently operational. This ensures a faster uptake within the business, enabling resources to be re-directed towards implementing the outputs and leveraging new information.



Our philosophy at Black Swan is to create the right environment using inclusive dialogues and collaboration that enable us to generate outputs that make business decisions clear. Our goal is to provide an unparalleled level of satisfaction and quality for our clients.

Reference

81392 | CHLR0010117

Number of Pages

38

Report Format

PDF

Black Swan Analysis Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Cholera - Pipeline Review, H2 2017
Cholera - Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcar...
18 Jul 2017 by Global Markets Direct USD $2,000 More Info
Cholera - Pipeline Insight, 2017
DelveInsight’s, “ Cholera -Pipeline Insights, 2017”, report provides comprehensive insights about pi...
10 Jul 2017 by Delve Insight USD $1,250 More Info
Cholera Global Clinical Trials Review, H1, 2017
Cholera Global Clinical Trials Review, H1, 2017SummaryGlobalData's clinical trial report, “Cholera G...
30 Jun 2017 by Global Data USD $2,500 More Info
Cholera-Pipeline Insights, 2017
DelveInsight’s, “ Cholera-Pipeline Insights, 2017”, report provides in depth insights on the pipelin...
30 May 2017 by Delve Insight USD $1,250 More Info
Cholera-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
DelveInsight’s Report, “Cholera-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 20...
30 May 2017 by Delve Insight USD $2,000 More Info
Global Cholera Vaccine Market Research Report Forecast 2017 to 2021
The Global Cholera Vaccine Market Research Report Forecast 2017-2021 is a valuable source of insight...
15 May 2017 by S&P Consulting USD $2,800 More Info
Global Cholera Vaccines Market Research Report Forecast 2017 to 2021
The Global Cholera Vaccines Market Research Report Forecast 2017-2021 is a valuable source of insig...
10 May 2017 by S&P Consulting USD $2,800 More Info
Cholera - Pipeline Review, H1 2017
Cholera - Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcar...
28 Feb 2017 by Global Markets Direct USD $2,000 More Info
Cholera Global Clinical Trials Review, H2, 2016
Cholera Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, “Cholera G...
30 Nov 2016 by Global Data USD $2,500 More Info
Cholera Global Clinical Trials Review, H1, 2016
Cholera Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, “Cholera G...
29 Feb 2016 by Global Data USD $2,500 More Info

This report is published by Black Swan Analysis

Black Swan Analysis, founded in 2007, is a unique analysis practice that provides robust valuations and commercialisation plans to optimise products in the healthcare industry. We know what it takes to succeed in this industry -we’ve seen what works and what doesn’t and we are committed to bringing insight and high quality solutions to our clients. In doing so we help them meet the many challenges of today’s complex healthcare marketplace.

The Black Swan team has a unique skill set: the ability to develop dynamic market forecasts and interactive patient flow models using a wide range of data including complex pathological and epidemiological information. As pharmaceutical and healthcare companies are challenged to deliver more specific targets that align with unmet medical needs. These modelling approaches are more commercially focused to meet the requirements of a changing healthcare environment.

We have the capability to provide an immediate and ‘hands-on’ approach with every client and where the right internal expertise is leveraged we can help find your optimal solution. Using our bespoke methodologies and frameworks we seek to assess the most challenging valuations.

The valuation outputs we generate can be easily integrated with any in-house existing financial systems, presentation styles or platforms that may be currently operational. This ensures a faster uptake within the business, enabling resources to be re-directed towards implementing the outputs and leveraging new information.

Our philosophy at Black Swan is to create the right environment using inclusive dialogues and collaboration that enable us to generate outputs that make business decisions clear. Our goal is to provide an unparalleled level of satisfaction and quality for our clients.

Download Free Report Summary PDF

Cholera Forecast for selected Asian Markets 2017-2027 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...